Study for patients having a stem cell transplant who do not have a matched related donor or matched unrelated donor

What we are studying

The purpose of this study is to see if treatment with a drug called cyclophosphamide is helpful to patients who need a stem cell transplant.

Who is Eligible

  • Genders:
    • Men
    • Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18 - 65

Eligibility Criteria

  • In remission for a hematologic malignancy requiring a stem cell transplant

What is involved

  • Treatment with cyclophosphamide
  • Blood draws at multiple timepoints after transplant



Contact Information

Study Coordinator
Vicki Lagerwey, RN

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.